Natural product promotes repair of injured spinal cord

Bibliography

• SEKHON LH, FEHLINGS MG: Epidemiology, demographics and pathophysiology of acute spinal cord injury. Spine (2001) 26(Suppl. 24):S2-S12.
   PubMed Web of Science ®Google Scholar
• SCHWAB ME, BARTHOLDI D: Degeneration and regeneration of axons in the lesional spinal cord. Physiol. Rev. (1996) 76:319-370.
   PubMed Web of Science ®Google Scholar
• NORENBERG MD, SMITH J, MARCILLO A: The pathology of human spinal cord injury: definging the problems. J. Neurotrama (2004) 21:429-440.
   PubMed Web of Science ®Google Scholar
• EIDELBERG E, STRAEHLEY D, ERSPAMER R, WATKINS CJ: Relationship between residual hindlimb-assisted locomotion and surviving axons after incomplete spinal cord injuries. Exp. Neurol. (1977) 56:312-322.
   PubMed Web of Science ®Google Scholar
• KWON BK, TETZLAF W, GRAUER JN, BEINER J, VACARO AR: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. (2004) 4:451-464.
   PubMedGoogle Scholar
• DI GIOVANNI S: Regeneration following spinal cord injury, from experimental models to human: where are we? Expert Opin. Ther. Targets (2006) 10(3):363-376.
   PubMed Web of Science ®Google Scholar
• DIETZ V, CURT A: Neurological aspects of spinal cord repair: promises and challenges. Lancet Neurol. (2006) 5:688-694.
   PubMed Web of Science ®Google Scholar
• THURET S, MOON LDF, GAGE FH: Therapeutic interventions after spinal cord injury. Nat. Rev. Neuroscience (2006) 7:628-643.
   PubMed Web of Science ®Google Scholar
• BRADBURY EJ, McMAHON SB: Spinal cord repair strategies: why do they work? Nat. Rev. Neuroscience (2006) 7:644-653.
   PubMed Web of Science ®Google Scholar
• LEVI AD, DANCAUSSE H, LI X, DUNCAN S, HORKEY L, OLIVIERA M: Peripheral nerve grafts promoting central nervous system regeneration after spinal cord injury in the primate. J. Neurosurg. (2002) 96:197-205.
   PubMed Web of Science ®Google Scholar
• CHENG H, LIAO KK, LIAO SF, CHUANG TY, SHIH YH: Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (2004) 29:E284-E288.
   PubMed Web of Science ®Google Scholar
• TAKAMI T, OUDEGA M, BATES ML et al.: Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J. Neurosci. (2002) 22:6670-6681.
   PubMed Web of Science ®Google Scholar
• IWANAMI A, YAMANE J, KATOH H et al.: Establishment of graded spinal cord injury model in a nonhuman primate: the common marmoset. J. Neurosci. Res. (2005) 80:172-181.
   PubMed Web of Science ®Google Scholar
• HUANG H, CHEN L, WANG H et al.: Influence of patients’ age on functional recovery after transplantation of olefactory ensheathing cells into injured spinal cord injury. China Med. J. (Engl.) (2003) 116:14988-1491.
   Google Scholar
• BIANCO JI, PERRY C, HARKIN DG, MACKAY-SIM A, FERON F. Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose. Glia (2004) 45:111-123.
   PubMed Web of Science ®Google Scholar
• FERON F, PERRY C, COCHRANE J et al.: Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain (2005) 128:2951-2960.
   PubMed Web of Science ®Google Scholar
• REIER PJ: Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx (2004) 1:424-451.
   PubMedGoogle Scholar
• FALCI S, HOLTZ A, AKESSON E et al.: Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. J. Neurotrauma (1997) 14:875-884.
   PubMed Web of Science ®Google Scholar
• THOMPSON FJ, REIER PJ, UTHMAN B et al.: Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia. J. Neurotrauma (2001) 18:931-945.
   PubMed Web of Science ®Google Scholar
• SCHULTZ SS: Adult stem cell application in spinal cord injury. Curr. Drug Targets (2005) 6:63-73.
   PubMed Web of Science ®Google Scholar
• CUMMINGS BJ, UCHIDA N, TAMAKI SJ et al.: Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. USA (2005) 102:14069-14074.
   PubMed Web of Science ®Google Scholar
• KIGERL K, POPOVICH P: Drug evaluation: Procord – a potential cell-based therapy for spinal cord injury. IDrugs (2006) 9:354-360.
   PubMed Web of Science ®Google Scholar
• HALL ED, SPRINGER JE: Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx (2004) 1:80-100.
   PubMedGoogle Scholar
• COLEMAN WP, BENZEL D, CAHILL DW et al.: A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J. Spinal Disord. (2000) 13:185-199.
   PubMedGoogle Scholar
• HURLBERT RJ: Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. (2000) 93:1-7.
   PubMed Web of Science ®Google Scholar
• AMADOR MJ, GUEST JD: An appraisal of ongoing experimental procedures in human spinal cord injury. J. Neurol. Phys. Ther. (2005) 29:70-86.
   PubMedGoogle Scholar
• BRADDOCK M, CAMPBELL CJ, ZUDER D: Current therapies for wound healing: electrical stimulation, biological therapeutics, and the potential for gene therapy. Int. J. Dermatol. (1999) 38:808-817.
   PubMed Web of Science ®Google Scholar
• WILLIAMS JA: Hedgehog and spinal cord injury. Expert Opin. Ther. Targets (2005) 9(6):1137-1145.
   PubMed Web of Science ®Google Scholar
• TUSZYNSKI MH, THAL L, PAY M et al.: A Phase I clinical trial of nerve growth factor gene therapy for Alzheimer’s disease. Nat. Med. (2005) 11:551-555.
   PubMed Web of Science ®Google Scholar
• SCHWAB ME, KAPFLHAMMER JP, BANDTLOW CE: Inhibitors of neurite growth. Ann. Rev. Neurosci. (1993) 16:565-595.
   PubMed Web of Science ®Google Scholar
• GRANDPRE T, NAKAMURA F, VARTANIAN T, STRITTMATTER SM: Identification of the Nogo inhibitor on axon regeneration as a reticulon protein. Nature (2000) 403:439-444.
   PubMed Web of Science ®Google Scholar
• DOMENICONI M, CAO Z, SPENCER T et al.: Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron (2002) 35:283-290.
   PubMed Web of Science ®Google Scholar
• WANG KC, KOPRIVICA V, KIM JA et al.: Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature (2002) 417:941-944.
   PubMed Web of Science ®Google Scholar
• PASTERKAMP RJ, GIGER RJ, RUITENBERG MJ et al.: Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol. Cell. Neurosci. (1999) 13:143-166.
   PubMed Web of Science ®Google Scholar
• PASTERKAMP RJ, ANDERSON PN, VERHAAGEN J: Peripheral nerve injury fails to induce gowth of lesioned ascending column axons into spinal cord scar tissue expressing the axon repellent semaphorin3A. Eur. J. Neurosci. (2001) 13:457-471.
   PubMed Web of Science ®Google Scholar
• DE WINTER F, OUDEGA M, LANKHORST AJ et al.: Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp. Neurol. (2002) 175:61-75.
   PubMed Web of Science ®Google Scholar
• YAZDANI U, TERMAN JR: The semaphorins. Genome Biol. (2006) 7:211.
   PubMed Web of Science ®Google Scholar
• GIRAUDON P, VINCENT P, VUAILLAT C: T-cells in neuronal injury and repair: semaphorins and related T-cell signals. Neuromol. Med. (2005) 7:207-216.
   PubMed Web of Science ®Google Scholar
• KIKUCHI K, KISHINO A, KONISHI O et al.: In vitro and in vivo characterisation of a novel semaphorin3A inhinitor, SM-216289. J. Biol. Chem. (2003) 278:42985-42991.
   PubMed Web of Science ®Google Scholar
• KUMAGAI K, HOSOTANI N, KIKUCHI K, KIMURA T, SAJI I: Xanthofulvin, a novel semaphorin inhibitor produced by a strain of Penicillium. J. Antibiot. (2003) 56:610-616.
   PubMed Web of Science ®Google Scholar
• KANEKO S, IWANAMI A, NAKAMURA M et al.: A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med. (2006) 12(12):1380-1389.
   PubMed Web of Science ®Google Scholar